rs764159927
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001292063.2(OTOG):c.4641G>T(p.Glu1547Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000806 in 1,538,114 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 18BInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| OTOG | ENST00000399397.6 | c.4641G>T | p.Glu1547Asp | missense_variant | Exon 36 of 56 | 5 | NM_001292063.2 | ENSP00000382329.2 | ||
| OTOG | ENST00000399391.7 | c.4677G>T | p.Glu1559Asp | missense_variant | Exon 35 of 55 | 5 | ENSP00000382323.2 | |||
| OTOG | ENST00000342528.2 | n.1979G>T | non_coding_transcript_exon_variant | Exon 12 of 22 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000586 AC: 89AN: 152006Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000336 AC: 47AN: 139704 AF XY: 0.000268 show subpopulations
GnomAD4 exome AF: 0.000830 AC: 1151AN: 1386108Hom.: 1 Cov.: 31 AF XY: 0.000795 AC XY: 542AN XY: 681988 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000586 AC: 89AN: 152006Hom.: 1 Cov.: 32 AF XY: 0.000566 AC XY: 42AN XY: 74230 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity (http://gnomad.broadinstitute.org). Computational tools predict that this variant is not damaging. -
OTOG: BP4, BS2 -
- -
In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function -
not specified Uncertain:1
The p.Glu1559Asp variant in OTOG has not been previously reported in individuals with hearing loss, but has been identified in 49/62630 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs764159927). Although this variant has been seen in the general population, it s frequency is not high enough to rule out a pathogenic role. Computational pred iction tools and conservation analysis suggest that the p.Glu1559Asp variant may not impact the protein, though this information is not predictive enough to rul e out pathogenicity. In summary, the clinical significance of the p.Glu1559Asp v ariant is uncertain. ACMG/AMP Criteria applied: BP4 (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at